No Further Restrictions. Without limiting Sections 3.1 through 3.6 and the exclusive licenses granted to Xxxxx pursuant to Section 7.1, each Party shall otherwise be free to exploit each New Nucleic Acid Platform. For example, (i) if the New Nucleic Acid Platform has applications outside of Non-Hepatocyte Neurodegeneration/Pain Targets or Non-Hepatocyte Cardiometabolic Targets, both Parties, subject to Sections 3.1 through 3.6 and the exclusive licenses granted to Lilly pursuant to Section 7.1, shall be free to exploit such New Nucleic Acid Platform for such purposes; and (ii) both Parties, subject to Sections 3.1 through 3.4 and the exclusive licenses granted to Xxxxx pursuant to Section 7.1, shall be unrestricted with respect to each New Nucleic ***Text Omitted and Filed Separately with the Securities and Exchange Commission. Confidential Treatment Requested Under
No Further Restrictions. Other than the express restrictions in this Section 14 and subject to Mobileye’s right to exclusively market the Initial Product if so agreed under Section 4.1 and in accordance with Section 4.2, nothing precludes Intel’s collaboration, disclosure, development, manufacturing, marketing, sale, or other exploitation of the whole or any part of the Initial Product or any Subsequent Product or any associated LiDAR technology.
No Further Restrictions. Rancho North, future Subdividers of any portion of the Rancho North Property and the Rancho Murieta North Association shall have no right to impose restrictions on the use of the Parks Access Easements and reasonable alternative access within the Rancho North Property that are inconsistent with the rights and easements granted under this Mutual Benefit Agreement to Rancho Murieta Association pursuant to Section 7.01, above.
No Further Restrictions. Except as expressly set forth in Section 2.2, nothing in this Agreement shall be construed as preventing or otherwise inhibiting HemoSense from (a) manufacturing some or all of its Coagulation Cocktail 2 requirements, or (b) obtaining some or all of its Coagulation Cocktail 2 requirements from third party(ies).
